On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Genetic studies have the potential to uncover new knowledge on the causes of disease, as well as help understand their complexity through identifying ‘sub-types’ that are underpinned by different pathways of pathogenesis. This information is crucial to inform the identification of novel targets for treatment, as well as methods of (non-invasive) diagnosis. I shall discuss recent progress in the field of endometriosis, covering our collaborative work within the International Endometriosis Genome Consortium, in which we are currently analysing 25 global datasets including >60,000 cases, detailed deep phenotype and comorbidity data, as well as functional ‘omics’ analyses. I will also discuss recent studies of somatic genetic mutations in endometriosis tissue which have received much ‘press’. Lastly, I will discuss how we can translate these genetic results into outcomes that are important to patients and clinicians.
